Stress Hormones and Human Cocaine Use - 7
NCT00000290 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to determine the HPA axis and adrenergic system activation in response to cocaine administration.
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Dorothy Hatsukami, Ph.D. · University of Minnesota
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-05-31
- Completion
- 2001-12-31
Countries
- United States
Study Locations
More Related Trials
-
Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.
NCT02255357 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals
NCT01963091 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
n-Acetylcysteine and Cocaine
NCT02141620 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
Glutaminergic Agents for Cocaine Abuse - 5
NCT00000280 ·Status: COMPLETED ·Phase: PHASE1
-
Relapse Patterns in Female Cocaine Users - 4
NCT00000287 ·Status: COMPLETED
-
Cocaine-Methylphendidate Interaction Study - 4
NCT00015067 ·Status: COMPLETED ·Phase: PHASE1
-
Dopamine Rhythms in Health and Addiction
NCT02233829 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Oxytocin in Cocaine Dependence
NCT01573273 ·Status: COMPLETED ·Phase: NA
-
Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine
NCT00338546 ·Status: WITHDRAWN ·Phase: PHASE1
-
Cocaine in Parotid Saliva, Blood and Urine - 4
NCT00000190 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
NCT00067535 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Phenytoin on Cocaine Use in Humans - 2
NCT00000285 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
NCT00032916 ·Status: UNKNOWN ·Phase: PHASE1
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
NCT00217997 ·Status: COMPLETED
-
Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
NCT00000350 ·Status: UNKNOWN ·Phase: PHASE1
-
Functional Connectivity Changes During Early Recovery as a Marker for Relapse
NCT02861820 ·Status: COMPLETED
-
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275 ·Status: COMPLETED ·Phase: PHASE4
-
New Approaches to Cocaine Abuse Medications (A) - 6
NCT00000271 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine and Pentoxifylline (BED IN 47)
NCT07086794 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Progesterone for the Treatment of Cocaine Dependence - 1
NCT00218257 ·Status: COMPLETED ·Phase: NA